Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 2;83(5):770-786.e9.
doi: 10.1016/j.molcel.2023.01.019. Epub 2023 Feb 16.

E3 ligase autoinhibition by C-degron mimicry maintains C-degron substrate fidelity

Affiliations

E3 ligase autoinhibition by C-degron mimicry maintains C-degron substrate fidelity

Daniel C Scott et al. Mol Cell. .

Abstract

E3 ligase recruitment of proteins containing terminal destabilizing motifs (degrons) is emerging as a major form of regulation. How those E3s discriminate bona fide substrates from other proteins with terminal degron-like sequences remains unclear. Here, we report that human KLHDC2, a CRL2 substrate receptor targeting C-terminal Gly-Gly degrons, is regulated through interconversion between two assemblies. In the self-inactivated homotetramer, KLHDC2's C-terminal Gly-Ser motif mimics a degron and engages the substrate-binding domain of another protomer. True substrates capture the monomeric CRL2KLHDC2, driving E3 activation by neddylation and subsequent substrate ubiquitylation. Non-substrates such as NEDD8 bind KLHDC2 with high affinity, but its slow on rate prevents productive association with CRL2KLHDC2. Without substrate, neddylated CRL2KLHDC2 assemblies are deactivated via distinct mechanisms: the monomer by deneddylation and the tetramer by auto-ubiquitylation. Thus, substrate specificity is amplified by KLHDC2 self-assembly acting like a molecular timer, where only bona fide substrates may bind before E3 ligase inactivation.

Keywords: Autoinhibition; C-END degron; CUL2; Cullin-RING Ligase; E3; KLHDC10; KLHDC3; Kinetic proofreading; NEDD8; Targeted protein degradation; allostery; higher-order assembly; protein-protein interaction; ubiquitin.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests B.A.S. is a member of the scientific advisory boards of Interline Therapeutics and BioTheryX. B.A.S. and D.C.S. are co-inventors of intellectual property licensed to Cinsano.

Figures

Figure 1.
Figure 1.. KLHDC2 displays selectivity for the diGly C-terminus of NEDD8.
(a) Superposition of the KLHDC2 SBD (surface representation colored slate) bound to the di-Gly motif of EPHB2 (sticks colored magenta), SELK (sticks colored light blue; 6DO3.pdb), and USP1 (red, 6DO5.pdb). Inset depicts the structural conservation of C-degron binding. C-terminal sequences from known physiological substrates and for UB and NEDD8. (b) Results of TR-FRET assay between KLHDC2 and Ric8b peptide and the dose-dependent TR-FRET in the presence of five di-Gly containing proteins. (c) Pulse-chase ubiquitylation assay monitoring the transfer of fluorescently labeled Lys-less UB from UB~UBE2R2B to KLHDC2 or the indicated diGly containing substrates. (d) Quantification of assays shown in (c). Results shown in (b-d) are representative of n=3 replicates.
Figure 2.
Figure 2.. KLHDC2’s C-terminal GlySer acts as a C-degron mimic.
(a) Crystal structure of full-length KLHDC2-EloBC. The crystallographic asymmetric unit contains subunits A (slate) and B (light pink) that interact with symmetry related subunits A’ (blue) and B’ (magenta). Insets depict the binding of KLHDC2’s C-degron mimic from protomer A (slate; left panel) to B (light pink) or protomer A’ (blue; right panel) to B (light pink) compared to USP1’s diGly C-degron bound to KLHDC2’s SBD (red, 6DO5.pdb). (b) Superposition of KLHDC2 SBD (slate) bound to a peptide derived from KLHDC2’s C-degron mimic and the SBD bound to USP1’s diGly C-degron (red; 6DO5.pdb). Inset shows the structural conservation of interactions. (c) SPR between the KLHDC2 SBD and various peptides with WT or mutant C-degron sequences from KLHDC2’s C-terminus. Asterisks denote estimated kinetic parameters as the extreme slow-off rate of the -GG peptide precluded accurate determinations.
Figure 3.
Figure 3.. KLHDC2-EloBC forms C-degron mimic dependent tetramers in solution.
(a) SEC-MALS of KLHDC2-EloBC. Nr is peak number with the mass (μg) of injected protein sample in parenthesis; Mp is kDa molar mass of the protein complex at the peak apex (molar mass of monomer shown in parenthesis); Mw is the weight-averaged molar mass from multi-angle light scattering; and Mw/Mn is the polydispersity of mass in the peak. (b) SV-AUC with AlexaFluor488 labeled KLHDC2-EloBC. The y-axis shows the normalized continuous sedimentation coefficient c(s) as a function of the sedimentation coefficient (S) at the indicated concentrations of KLHDC2-EloBC (left panel). Species population plots as a function of KLHDC2-EloBC concentration (right panel). Model-derived dissociation constants KD14 for tetramer to monomer dissociation, KD12 for KLHDC2-EloBC dimerization, and KD24 for dimer-dependent tetramerization are shown. Root-mean square deviation (Rmsd) of the fit to the model is shown. (c) Superposition of promoters A and B from the KLHDC2-EloBC tetramer. Structural elements including the SBD, BC-box, and EloBC align well, with structural differences restricted to the extreme C-terminal degron mimic sequence of KLHDC2 subunits. (d) Cartoon schematic of the KLHDC2-EloBC tetramer highlighting locations of inter-molecular interactions between protomers and their associated tetramerization elements. (e) Primary structure of KLHDC2 highlighting positional boundaries for the SBD, BC-box, and CUL2-box. The C-terminal 12 residues of the C-degron mimic are shown. Ribbon diagrams highlighting tetramerization elements and the C-degron mimic between KLHDC2 protomers A and B (left panel) or A’ and B (right panel). (f) Coomassie stained native gel of WT KLHDC2-EloBC or indicated mutants monitoring the formation of oligomeric species.
Figure 4.
Figure 4.. The KLHDC2-EloBC tetramer does not bind protein substrates.
(a) Fluorescence-scan of native gel electrophoresis monitoring time dependence for binding of fluorescent SELK (FAMSELK) to WT or the indicated C-degron mimic mutants. (b) same as in (a) but monitoring concentration dependence of FAMSELK or FAMUSP1 after 4-hour pre-incubation. (c) same as in (a) but monitoring complex formation between TAMRA-labeled CUL2 (left panel) or TAMRA-labeled NEDD8~CUL2 (right panel) and FAMSELK. Co-migration of CUL2 and FAMSELK results in yellow bands. (d) Surface representations of the cryo-EM structure of KLHDC2-EloBC bound to CUL2-RBX1. (e) Models for ubiquitylation complexes with tetrameric KLHDC2-EloBC and substrate bound monomer KLHDC2. Note positioning of protomer A or A’ correlates with the predicted positioning of a diGly substrate. (f) Pulse-chase ubiquitylation reactions monitoring the transfer of fluorescently labeled WT UB from UB~UBCH5B to WT KLHDC2-EloBC or the indicated C-degron mutants with or without the addition of SELK.
Figure 5.
Figure 5.. KLHDC2-EloBC substrate mimic-induced tetramers select for bona fida substrates through a proofreading mechanism.
(a) Pulse-chase ubiquitylation reactions monitoring how pre-incubation of a USP1-NEDD8~CUL2KLHDC2 complex affects transfer of UB from UB~UBE2R2 to substrate with WT or -KK monomeric KLHDC2-EloBC. (b) same as in (a) but with NEDD8. Note that pre-incubation results in partitioning of UB from KLHDC2 to USP1 but not NEDD8 in a tetramer-dependent fashion. (c) SPR traces monitoring the binding of SELKFragment, USP1Fragment, or NEDD8 proteins to the KLHDC2 SBD. Association rates (ka), dissociation rates (kd), and the equilibrium binding constants (KD) obtained from fits are shown. (d), same as in (c), but with the indicated GlySer insertion mutants of NEDD8. (e) same as in (a) but with -KK KLHDC2 and NEDD8 or the indicated insertion mutant substrates. (f) same as in (e) but with WT KLHDC2.
Figure 6.
Figure 6.. KLHDC2 C-degron mimic-induced tetramerization affects myriad CRL2KLHDC2 biochemical activities.
(a) Normalized rates of CUL2 neddylation by NEDD8~UBE2M in the absence (left panel) or presence (right panel) of CAND1 and with WT or the indicated KLHDC2-EloBC C-degron mutants and with or without SELK peptide. (b) Western blot monitoring NEDD8~CUL2 deneddylation by CSN in the absence or presence of WT or the indicated KLHDC2-EloBC C-degron mutants and with or without the addition of SELK peptide or a MBP-SELK fusion protein. (c) Model of monomeric CUL2KLHDC2 neddylation complex. The relative position of tetramerization elements 1 and 2 are highlighted. (d) Velocity of CUL2 neddylation versus NEDD8~UBE2M concentration. Rates of NEDD8~CUL2 formation were measured in the presence of CUL2 alone (circles) or CUL2KLHDC2(-KK). Data were fit to the Michaelis-Menten model using Graphpad Prism software. (e) same as in (a) but monitoring the stimulation of CUL2 neddylation in the presence of WT or the indicated KLHDC2-EloBC mutants with or without SELK. All results represent replicates of n=3.
Figure 7.
Figure 7.. KLHDC2-EloBC appears to form C-degron mimic-dependent tetramers in cells that control CUL2KLHDC2 function.
(a) HEK-293T cells were transiently transfected with constructs for FLAG-tagged WT or C-degron mutant KLHDC2. Immunoprecipitations were performed in the absence or presence of the indicated supplements followed by Western blotting. (b) Steady-state levels of proteins from WT U2OS cells, KLHDC2 knockout (KO), or KLHDC2 KO cells with ectopic expression of the indicated KLHDC2 proteins. (c) same as (b), monitoring the steady-state levels of the diGly C-terminal fragment of USP1. (d) Quantification of steady-state levels of UPS1 fragment from (c); (technical replicates are shown of n=3). (e) same as (b) but monitoring the steady-state levels of NEDD8. (f) same as (d) but for NEDD8. (g) Cartoon model for substrate selectivity amplification by the C-degron mimic KLHDC2-EloBC tetramer. Typical CRL SRs (top panel) poorly discriminate between bona fide substrates with fast association rates and “non-substrates” with slow association rates. In contrast, the C-degron mimic KLHDC2-EloBC tetramer (bottom panel) is unable to directly engage substrates. Substrates must “capture” the KLHDC2-EloBC monomer upon dissociation from tetramer. Thus, substrate selectivity is achieved by enabling SR-substrate complex formation for only substrates that have association rates that are sufficiently fast to capture monomer prior to tetramer reformation.

Comment in

References

    1. Li W, Bengtson MH, Ulbrich A, Matsuda A, Reddy VA, Orth A, Chanda SK, Batalov S, and Joazeiro CA (2008). Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle’s dynamics and signaling. PLoS One 3, e1487. 10.1371/journal.pone.0001487. - DOI - PMC - PubMed
    1. Hershko A, Ciechanover A, and Varshavsky A (2000). Basic Medical Research Award. The ubiquitin system. Nat Med 6, 1073–1081. 10.1038/80384. - DOI - PubMed
    1. Ravid T, and Hochstrasser M (2008). Diversity of degradation signals in the ubiquitin-proteasome system. Nat Rev Mol Cell Biol 9, 679–690. 10.1038/nrm2468. - DOI - PMC - PubMed
    1. Hatakeyama S, and Nakayama KI (2003). Ubiquitylation as a quality control system for intracellular proteins. J Biochem 134, 1–8. 10.1093/jb/mvg106. - DOI - PubMed
    1. Kevei E, Pokrzywa W, and Hoppe T (2017). Repair or destruction-an intimate liaison between ubiquitin ligases and molecular chaperones in proteostasis. FEBS Lett 591, 2616–2635. 10.1002/1873-3468.12750. - DOI - PMC - PubMed

Publication types

LinkOut - more resources